Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
Craig Karson,1 Ruth A Duffy,2 Anna Eramo,3 Anna-Greta Nylander,4 Steve J Offord5 1CNK Consultants, Delray Beach, FL, 2Medical Affairs – Neuroscience, Otsuka America Pharmaceutical, Inc., Princeton, NJ, 3Medical Affairs & Phase IV Clinical Affairs, Lundbeck LLC, Deerfield, IL, USA;...
Enregistré dans:
Auteurs principaux: | Karson C, Duffy RA, Eramo A, Nylander AG, Offord SJ |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ed9f8cc055374076827f5e2c74dd0a90 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Implementation and Review of Cognitive Remediation Training for First Episode Psychosis in Singapore
par: Nigel Ian Ming Chong, et autres
Publié: (2021) -
Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
par: Suguru Nakajima, et autres
Publié: (2021) -
Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
par: Ryan Sai-Ting Chu, et autres
Publié: (2021) -
Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
par: Ping Yin, et autres
Publié: (2021) -
Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
par: Matei VP, et autres
Publié: (2020)